Introduction
Sacral insufficiency fracture is a common clinical problem in elderly osteoporotic individuals. This debilitating pathological condition may subject the patients to the known complications of long-term immobilisation like respiratory and urinary tract infections, bed sores and deep venous thrombosis with or without subsequent pulmonary embolism [1] . Treatment of sacral insufficiency fractures is primarily based upon bed rest along with analgesic coverage and physical therapy/rehabilitation as soon as tolerated. This conservative approach, however, is known to be time-consuming, as several months must have elapsed before obtaining significant recovery [2] . Furthermore, pre-existing osteoporosis may progress secondary to such a relatively long period of inactivity. Percutaneous placement of iliosacral screws is a relatively new minimally invasive alternative [2] [3] [4] [5] . It is noteworthy, however, that besides the recorded technical difficulty of this approach, stable sacroiliac osteosynthesis may not be fully achieved in bone chronically weakened by osteoporosis [5] .
With the successful introduction of cement augmentation of cancellous bone in the treatment of osteoporotic vertebral compression fractures, there has been rising interest in applying the same concept to treat sacral insufficiency fractures [6] [7] [8] [9] . Currently, there are some encouraging reports on the favourable outcome of patients subjected to short-axis sacroplasty. As we have previously introduced the advantageous CT-guided long-axis approach that reduces the number of needles used and provides precision, safety and speed [9] , we were interested in resuming our experience, along with the clinical outcome of the first cohort of patients treated with this new technique.
Materials and methods
Institutional review board approval was obtained for the present analysis, which included 19 patients (16 women and 3 men; mean age, 78 years; age range, 58 to 97 years) who were treated with percutaneous sacroplasty for sacral insufficiency fractures. In our institute, all patients must give their written informed consent after having the procedures explained to them. Using the long-axis approach, as previously described by Binaghi et al. [9] , standard prone positioning of the patients in the CT unit under conscious sedation with midazolam was chosen. CT data were obtained with an eight-row CT unit (Lightspeed Ultra; GE Medical Systems, Milwaukee, WI). The area to be treated was prepared in a strictly sterile manner, and then local anaesthesia was applied. The first part of the CT guidance dedicated to the placement of the needle is set in incremental mode, with the tilting of the CT gantry in a plane as parallel as possible to that of the body of the sacrum, in order to visualise the complete intraosseous path along which the needle has to be advanced. When needed, some specific positioning pillows were placed under the patient's thighs or knees to adjust the vertical position of the sacral bone in order to fit the tilting limits of the CT gantry. After a small skin incision, an 11-gauge beveled vertebroplasty needle (OsteoSite Bone Biopsy Needle Set, Cook, Bjaeverskov, Denmark) was positioned at the entry point to the sacrum. Then, the needle was inclined, directed and advanced according to the laser alignment light of the CT unit in order to achieve precise control of the access between the sacroiliac joints and the sacral foramina, going from the inferior aspect to the superior aspect of the fracture. Accordingly, complete visualisation of the needle on the same CT slice could be achieved until its final destination. The successive injection of polymethylmethacrylate (PMMA, Vertebroplastic, DePuy Acromed Inc., Raynham, MA) was performed under helical CT control, with the CT gantry in a vertical position. Two 10-ml highpressure injector sets (OsteoForce, Cook, Bjaeverskov, Denmark) were simultaneously used by two operators on both sides of the fracture for the injection of PMMA. An average of 6 ml of PMMA was delivered on each side of the fracture; the injection was carried out very slowly with constant checking for any cement leakage towards the sacral foramina or the sacroiliac joints. If leakage was going to appear, the bevel of the needle had to be immediately directed to the opposite direction of the leakage or the needle had to be withdrawn slightly. During PMMA administration, the needles were progressively withdrawn from the first sacral level towards the entry point located on the third or fourth sacral level, under intermittent observation by successive helical CT series, in order to fill the entire length of the fracture.
To obtain the follow-up data, all subjects were first contacted by telephone to obtain their oral agreement to participation after explaining the aim of the study. In the case of agreement, each patient was required to score his pain (1, none; 10, worst) before and after sacroplasty (at 1, 4, 24 and 48 weeks) using the Visual Analogue Scale (VAS). Using a 5-point scale (1 normal, no pain; 2 normal with pain; 3, limited, with pain; 4, wheel chair; 5, bedridden) all patients were asked about the evolution of their post-interventional mobility. Furthermore, the use of analgesics (narcotic/non-narcotic) after discharge until the day of interrogation was also recorded. The pre-sacroplasty state of mobility and analgesic use were both obtained from the inpatient hospital charts of each individual subject. The telephone interview was then terminated by a question about the general post-procedure satisfaction. Besides any potential treatment failure, peri-procedural complications like penetration of the sacral cortex, haemorrhage or cement extrusion into the sacral neuroforamina were recorded. 
Results
The most likely provocative factors for sacral insufficiency fracture in our series were osteoporosis (n=17) and postradiotherapy osteopenia (n=2). Sixteen patients had bilateral sacral alar fractures and underwent percutaneous sacroplasty on either side, whereas three patients had unilateral fractures. Among the entire study population, 18 (95%) patients were available at all follow-up intervals, whereas 1 patient died 4 months after the procedure of unrelated causes. The mean pre-procedure VAS score was 8±1.9 (range, 2 to 10). This rapidly and significantly (P< 0.001, ANOVA analysis) declined in the first week after the procedure (mean 4±1.4, range, 1 to 7) followed by a gradual but still significant (P<0.001, ANOVA analysis) decrease throughout the rest of the follow-up period at 4 weeks (mean 3±1.1, range, 1 to 5), 24 weeks (mean 2.2± 1.1, range, 1 to 5) and 48 weeks (mean 1.6±1.1, range, 1 to 5) (Fig. 1) . Eleven (58%) patients were under narcotic analgesia before sacroplasty, whereas eight (42%) patients were using non-narcotics (Fig. 2) . Corresponding values after the procedure were 2/19 (10%) (narcotic, one of them was on reserve) and 10/19 (53%) (non-narcotic). The remaining 7 (37%) patients did not address post-procedure analgesic use as shown in Fig. 2 . The evolution of postinterventional mobility was favourable in the study group as they revealed a significant improvement in their mobility point scale (pre-procedure mean value, 4.3±1; range, 3 to 5 vs. 2.3±1.2; range, 1 to 5 for post-procedure, P<0.001, paired t test). It is worth noting that 11 (58%) patients revealed a full return to normal mobility (Fig. 3) . Fifteen (79%) patients were generally satisfied with their treatment and recorded a significant improvement in their lifestyle (Fig. 4) . On the other hand, four patients with persisting sacralgia (n=1) and low backache (n=3) were not generally satisfied. The origin of sacralgia in the first patient was inadequate cement distribution along the transverse component of an oblique sacral fracture (Fig. 5 ). In the other three patients with persisting low backache, despite adequate and homogeneous cement distribution along the sacral fracture lines, two had nonconsolidating fractures of the transverse processes of the fifth lumbar vertebra and of the iliac bone, whereas the third was known to have an untreated lower lumbar disc herniation. During the hospitalisation period, no major complications were encountered, and most patients could be discharged within 24 h of the procedure.
Discussion
The incidence of sacral insufficiency fracture is increasing within the rapidly growing population of elderly people where osteoporosis prevails. Other, less frequent risk factors include rheumatoid arthritis, prolonged corticosteroid treatment and pelvic irradiation [10] . Given that the overall 1-year mortality rate associated with pelvic insufficiency fractures is~14% [11] , every effort must be made to diagnose early and efficiently treat this pathological condition. Unlike the well-established clinical benefit of percutaneous vertebroplasty, sacroplasty does not represent the standard care for patients who present with sacral insufficiency fracture. This is primarily related to the obvious lack of studies that consider its outcome and safety profile. In the present report, we observed a dramatic response to this therapeutic option in almost all patients with sacral insufficiency fracture. In fact, most patients addressed a significant reduction in their pain score along with remarkable improvement in their daily mobility (Figs. 1, 2 and 3) . This is not surprising as the consolidating effect of the PMMA has the potential to reduce or even suppress the motion within the fracture line that provokes pain through stimulating the periosteal nerve endings along the fracture interface. Second, its thermogenic effect has been claimed to be somewhat analgesic and is thought to be the main contributor to short-term pain relief [10] . Since the first report on sacroplasty for the treatment of sacral insufficiency fractures was published, five dedicated studies have evaluated the clinical outcomes of 120 patients who were subjected to this new treatment approach [1, [12] [13] [14] [15] . These studies invariably reported rapid and substantial pain relief, which led to significant improvement in the overall quality of life. Our results lend support to these findings; it has to be noted, however, that some complications like transient radiculitis and cement extravasation into the central canal, sacral foramina or sacroiliac joint were previously encountered. These events could be efficiently contained by immediate measures to minimise the propagation of any hazardous effect. In our series, however, we did not observe any of the aforementioned complications, potentially because of applying the CTguided long-axis approach, which facilitates cement delivery along the fracture line using a single entry point. Furthermore, this approach allows better determination of the needle depth and trajectory into the sacral mass and consequently facilitates its manipulation during the procedure. We believe that the CT-guided long-axis sacroplasty is advantageous over the same fluoroscopy-guided approach, especially in avoiding the risk of penetrating the cephalad cortex of the S1 sacral ala that usually leads to cement extrusion into the adjacent soft tissues [16] . Additionally, its application in obese patients may also facilitate the procedures and reduce the overall time required for cement installation. It has to be recognised, however, that real-time monitoring of cement installation using fluoroscopy is a vital advantage that is not currently provided by the CT-guided approach. Whether long-axis sacroplasty is also feasible for traumatic, non-displaced sacral fractures in patients with senile osteoporosis needs to be established.
Incomplete treatment success in the form of persisting sacralgia was observed in 1/19 patients (0.5%) in the present series. The reason why sacroplasty failed in this patient was inadequate cement distribution along the transverse component of an oblique sacral fracture (Fig. 5 ). This may imply that for sacral fractures with mixed longitudinal and transverse components, a traditional short-axis sacroplasty should be taken into consideration besides the long-axis approach. Three patients with successfully treated unilateral (n=1) and bilateral (n=2) sacral fractures addressed persisting low backache after the procedure. In fact, two of these three patients had non-consolidating fractures of the transverse processes of the fifth lumbar vertebra and of the iliac bone, respectively. We believe that these unhealed fractures were responsible for the patients' symptomatology as they had adequate and homogeneous cement distribution along their sacral fracture lines. The third patient was known to have an untreated disc hernia of the lower lumbar segment.
A limitation of the present study is its low number of patients (n=19). Despite this fact, our series still represents the largest one yet published that selectively presents the outcome of patients subjected to the long-axis sacroplasty approach. A second limitation is that we did not randomise a control group with a conservative treatment algorithm in our study design. It has to be recognised, however, that the remarkable improvement in the post-procedure mobility of the patients, along with the significant short-term reduction in pain score and analgesic dependence, are obvious arguments in favour of sacroplasty being the limiting factor in patient improvement in the present series, different from the spontaneous healing phase of conservative treatment, which needs several months to evoke a similar effect.
Conclusion
Long-axis percutaneous sacroplasty is a suitable, minimally invasive treatment option for patients who present with sacral insufficiency fractures. Future studies with larger patient numbers are warranted to determine any unrecognised limitations of this therapeutic approach, along with estimating its utility for traumatic, nondisplaced sacral injuries.
